Protalix Biotherapeutics, Inc. (PLX)
1.75
+0.01
(+0.57%)
USD |
NYAM |
Dec 09, 16:00
1.745
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Profit Margin (Quarterly): 13.19% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| GlucoTrack, Inc. | -- |
| PAVmed, Inc. | -120.2K% |
| AIM ImmunoTech, Inc. | -12.63K% |
| Perspective Therapeutics, Inc. | -12.43K% |
| Armata Pharmaceuticals, Inc. | -2.30K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.06% |
| Return on Assets | 7.30% |
| Return on Invested Capital | 10.63% |
| Gross Profit Margin (Quarterly) | 53.37% |
| Operating Margin (Quarterly) | 11.94% |
| Return on Net Operating Assets | 14.42% |